REVITALYZ Trademark
Trademark Overview
On Monday, April 15, 2024, a trademark application was filed for REVITALYZ with the United States Patent and Trademark Office. The USPTO has given the REVITALYZ trademark a serial number of 98499824. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, October 29, 2024. This trademark is owned by Flamel Ireland Limited. The REVITALYZ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific research, biochemical research, and pharmaceutical research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; scientific study and research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related disease; testing of pharmaceuticals; provision of pharmaceutical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis for research purposes
General Information
| Serial Number | 98499824 |
| Word Mark | REVITALYZ |
| Filing Date | Monday, April 15, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Tuesday, October 29, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | REVITALIZE |
| Goods and Services | Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific research, biochemical research, and pharmaceutical research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; scientific study and research in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related disease; testing of pharmaceuticals; provision of pharmaceutical information in the fields of nervous system diseases and disorders, sleep disorders, narcolepsy, cataplexy, excessive daytime sleepiness, idiopathic hypersomnia, and other sleep related diseases; provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis for research purposes |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 15, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Flamel Ireland Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DUBLIN 2 D02T380
IE |
Trademark Events
| Event Date | Event Description |
| Monday, April 15, 2024 | NEW APPLICATION ENTERED |
| Tuesday, October 29, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 29, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 29, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, September 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 28, 2024 | ASSIGNED TO EXAMINER |
